Sunesis Pharmaceuticals, Inc. - Investors Media - Overview

Sunesis overview for investors and media

OVERVIEW

The web site ir.sunesis.com presently has an average traffic ranking of zero (the smaller the more traffic). We have parsed zero pages inside the web site ir.sunesis.com and found three websites associating themselves with ir.sunesis.com.
Links to this site
3

IR.SUNESIS.COM TRAFFIC

The web site ir.sunesis.com is seeing diverging amounts of traffic through the year.
Traffic for ir.sunesis.com

Date Range

1 week
1 month
3 months
This Year
Last Year
All time
Traffic ranking (by month) for ir.sunesis.com

Date Range

All time
This Year
Last Year
Traffic ranking by day of the week for ir.sunesis.com

Date Range

All time
This Year
Last Year
Last Month

LINKS TO WEBSITE

WHAT DOES IR.SUNESIS.COM LOOK LIKE?

Desktop Screenshot of ir.sunesis.com Mobile Screenshot of ir.sunesis.com Tablet Screenshot of ir.sunesis.com

IR.SUNESIS.COM SERVER

Our crawlers revealed that a single page on ir.sunesis.com took zero milliseconds to stream. I could not detect a SSL certificate, so in conclusion our web crawlers consider this site not secure.
Load time
0 sec
SSL
NOT SECURE
IP
104.68.127.245

SITE TITLE

Sunesis Pharmaceuticals, Inc. - Investors Media - Overview

DESCRIPTION

Sunesis overview for investors and media

PARSED CONTENT

The web site has the following on the site, "Sunesis is a biopharmaceutical company focused on the development and commercialization of new oncology therapeutics for the potential treatment of solid and hematologic cancers." I noticed that the web site also said " Our efforts are currently focused primarily on QINPREZO vosaroxin for the potential treatment of acute myeloid leukemia AML." They also said " Sunesis Pharmaceuticals to Present at the 2015 Wedbush PacGrow Healthcare Conference. Wednesday, August 12, 2015." The meta header had Sunesis as the first optimized keyword. This keyword is followed by Sunesis, Sunesis Pharmaceuticals, and clinical-stage biopharmaceutical which isn't as important as Sunesis. The other words ir.sunesis.com uses is small-molecule therapeutics. pipeline is included and might not be seen by search parsers.

SEE SIMILAR BUSINESSES

Superior Energy IR - Investor Relations

Complete Energy Services â Fluid Management. Complete Energy Services â Well Services. Concentric Pipe and Tool Rentals. Superior Energy Services - Completion Services. Superior Energy Services - Marine Technical Services. Superior Energy Services - Well Services. Mission, Vision, Values. Health, Safety, Environment and Quality. Onshore Completion and Workover Services.

Overview Super Micro Computer, Inc.

Read more about our management team here. Read more about our Board of Directors here. Supermicro Unleashes Innovative New Resource Saving Datacenter Solutions at Cloud Expo Europe 2018. And are also available in pertinent news releases from the company.

Investor Relations - Supernus Pharmaceuticals, Inc.

Delayed at least 20 minutes. 2018 Supernus Pharmaceuticals, Inc.

SÜSS MicroTec - Investor Relations

Willkommen im Investor Relations Bereich der SÜSS MicroTec AG. Das Ziel der Investor Relations Arbeit bei SÜSS MicroTec ist es für eine angemessene Bewertung unserer Aktie am Kapitalmarkt zu sorgen. Aus diesem Grund pflegen wir einen intensiven Kontakt zu unseren Aktionären und stehen darüber hinaus im offenen und kontinuierlichen Dialog mit dem Kapitalmarkt.

Investor Relations Swire Properties

Notices - Replacement of Lost Share Certificates. List of Directors and their Role and Function. Memorandum and Articles of Association. Equal Opportunities and Diversity Council.